Literature DB >> 19412929

Racial differences in the diagnosis of Parkinson's disease.

Nabila Dahodwala1, Andrew Siderowf, Ming Xie, Elizabeth Noll, Matthew Stern, David S Mandell.   

Abstract

The objective of this cohort study was to determine the incidence of Parkinson's disease (PD) and the effects of race/ethnicity, other demographic characteristics, geography, and healthcare utilization on probability of diagnosis. The authors used the Pennsylvania state Medicaid claims dataset from 1999 to 2003 to identify newly diagnosed cases of PD among the 182,271 Medicaid enrolled adults age 40-65; 319 incident cases of PD were identified. The 4-year cumulative incidence of PD was 45 per 100,000; 54 per 100,000 among whites, 23 per 100,000 among African-Americans and 40 per 100,000 among Latinos (P < 0.0001), corresponding to a relative risk (RR) of PD of 0.43 for African-Americans (P < 0.0001) compared with whites. After adjusting for age, sex, geography, reason for Medicaid eligibility, and average number of visits, African-Americans were still half as likely to be diagnosed with PD as whites (RR 0.45, P < 0.0001). Older age, more healthcare visits and Medicaid eligibility because of income alone also were significantly associated with PD diagnosis, while male sex was not. Observed racial differences in incidence of PD are not explained by differences in age, sex, income, insurance or healthcare utilization but still may be explained by biological differences or other factors such as education or aging beliefs. Better understanding of the complex biological and social determinants of these disparities is critical to improve PD care. (c) 2009 Movement Disorder Society.

Entities:  

Mesh:

Year:  2009        PMID: 19412929      PMCID: PMC2858583          DOI: 10.1002/mds.22557

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

1.  Managed care in three states: experiences of low-income African Americans and Hispanics.

Authors:  W A Leigh; M Lillie-Blanton; R M Martinez; K S Collins
Journal:  Inquiry       Date:  1999       Impact factor: 1.730

2.  Risk tables for parkinsonism and Parkinson's disease.

Authors:  Alexis Elbaz; James H Bower; Demetrius M Maraganore; Shannon K McDonnell; Brett J Peterson; J Eric Ahlskog; Daniel J Schaid; Walter A Rocca
Journal:  J Clin Epidemiol       Date:  2002-01       Impact factor: 6.437

3.  Racial disparities in service use among Medicaid beneficiaries after mandatory enrollment in managed care: a difference-in-differences approach.

Authors:  M Tai-Seale; D Freund; A LoSasso
Journal:  Inquiry       Date:  2001       Impact factor: 1.730

4.  Geographic variation in health care and the problem of measuring racial disparities.

Authors:  Katherine Baicker; Amitabh Chandra; Jonathan S Skinner
Journal:  Perspect Biol Med       Date:  2005       Impact factor: 1.416

Review 5.  The diagnosis of Parkinson's disease.

Authors:  Eduardo Tolosa; Gregor Wenning; Werner Poewe
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

6.  Occurrence of Parkinson's disease in black patients at Charity Hospital in New Orleans.

Authors:  R M Paddison; R P Griffith
Journal:  Neurology       Date:  1974-07       Impact factor: 9.910

7.  Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

Authors:  I I Kessler
Journal:  Am J Epidemiol       Date:  1972-10       Impact factor: 4.897

8.  The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993.

Authors:  R Mayeux; K Marder; L J Cote; J Denaro; N Hemenegildo; H Mejia; M X Tang; R Lantigua; D Wilder; B Gurland
Journal:  Am J Epidemiol       Date:  1995-10-15       Impact factor: 4.897

9.  Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey.

Authors:  Katia Noyes; Hangsheng Liu; Robert Holloway; Andrew W Dick
Journal:  Mov Disord       Date:  2007-03-15       Impact factor: 10.338

10.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

Authors:  Stephen K Van Den Eeden; Caroline M Tanner; Allan L Bernstein; Robin D Fross; Amethyst Leimpeter; Daniel A Bloch; Lorene M Nelson
Journal:  Am J Epidemiol       Date:  2003-06-01       Impact factor: 4.897

View more
  24 in total

Review 1.  An update on the diagnosis and treatment of Parkinson disease.

Authors:  Philippe Rizek; Niraj Kumar; Mandar S Jog
Journal:  CMAJ       Date:  2016-05-24       Impact factor: 8.262

2.  Delayed Parkinson's disease diagnosis among African-Americans: the role of reporting of disability.

Authors:  Nabila Dahodwala; Jason Karlawish; Andrew Siderowf; John E Duda; David S Mandell
Journal:  Neuroepidemiology       Date:  2011-04-20       Impact factor: 3.282

3.  Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).

Authors:  Jori E Fleisher; Nabila A Dahodwala; Sharon X Xie; Mark Mayo; Daniel Weintraub; Joshua Chodosh; Judy A Shea
Journal:  J Parkinsons Dis       Date:  2016-04-02       Impact factor: 5.568

4.  Perspective: Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin.

Authors:  Mark F McCarty; Aaron Lerner
Journal:  Adv Nutr       Date:  2021-03-31       Impact factor: 8.701

5.  Hispanic Perspectives on Parkinson's Disease Care and Research Participation.

Authors:  Lisa Damron; Irene Litvan; Ece Bayram; Sarah Berk; Bernadette Siddiqi; Holly Shill
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Validation of an instrument to measure older adults' expectations regarding movement (ERM).

Authors:  Nabila Dahodwala; Jason Karlawish; Judy A Shea; Cynthia Zubritsky; Matthew Stern; David S Mandell
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

7.  The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.

Authors:  Tianhong Pan; Julie Zhu; Wen-Jen Hwu; Joseph Jankovic
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

8.  The endotoxin-induced neuroinflammation model of Parkinson's disease.

Authors:  Kemal Ugur Tufekci; Sermin Genc; Kursad Genc
Journal:  Parkinsons Dis       Date:  2011-01-18

9.  Patient considerations in early management of Parkinson's disease: focus on extended-release pramipexole.

Authors:  Fatai Kunle Salawu
Journal:  Patient Prefer Adherence       Date:  2012-01-16       Impact factor: 2.711

Review 10.  Epidemiology of Parkinson's Disease-East Versus West.

Authors:  Masoom M Abbas; Zheyu Xu; Louis C S Tan
Journal:  Mov Disord Clin Pract       Date:  2017-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.